DelaneyC.P.Clinical perspective on postoperative ileus and the effect of opiates.Neurogastroenterol Motil2004; 16(suppl 2): 61–6.
2.
WolffB.G., LeslieJ.B., SaclaridesT.J.Integrating new agents for postoperative ileus into multimodal protocols.Contemp Surg2006; Suppl: 1–24.
3.
GoldsteinJ.L., MatuszewskiK.A., DelaneyC.P.Inpatient economic burden of postoperative ileus associated with abdominal surgery in the United States.P&T2007; 32: 82–90.
4.
BehmB., StollmanN.Postoperative ileus: etiologies and interventions.Clin Gastroenterol Hepatol.2003; 1: 71–80.
5.
CarrollJ., AlaviK.Pathogenesis and management of postoperative ileus.Clin Colon Rectal Surg2009; 22: 47–50.
6.
TagiA., HongX., MistralettiG.Thoracic epidural analgesia facilitates the restoration of bowel function and dietary intake in patients undergoing laparoscopic colon resection using a traditional, nonaccelerated, perioperative care program.Surg Endosc2007; 21: 247–52.
7.
ZinggU., MiskovicD., HamelC.T.Influence of thoracic epidural analgesia on postoperative pain relief and ileus after laparoscopic colorectal resection: benefit with epidural analgesia.Anesth Anal2008; 106: 959–64.
8.
KurubaR., FayardN., SnyderD.Epidural analgesia and laparoscopic technique do not reduce incidence of prolonged ileus in elective colon resections.Am J Surg2012; 204: 613–8.
9.
HolteK., KehletH.Postoperative ileus: a preventable event.Br J Surg2000; 87: 1480–93.
10.
KalffJ.C., SchrautW.H., SimmonsR.L.Surgical manipulation of the gut elicits an intestinal muscularis inflammatory response resulting in postsurgical ileus.Ann Surg1998; 228: 652–63.
SenagoreA.J., BauerJ.J., DuW.Alvimopan accelerates gastrointestinal recovery after bowel resection regardless of age, gender, race, or concomitant medication use.Surgery2007; 142: 478–86.
13.
HerzogT.J., ColemanR.L., GuerrieriJ.P.Jr.A double blind, randomized, placebo-controlled phase III study of the safety of alvimopan in patients who undergo simple total abdominal hysterectomy.Am J Obstet Gynecol2006; 195: 445–53.
14.
WolffB.G., ViscusiE.R., DelaneyC.P.Patterns of gastrointestinal recovery after bowel resection and total abdominal hysterectomy: pooled results from the placebo arms of alvimopan phase III North American clinical trials.J Am Coll Surg2007; 205: 43–51.
15.
DelaneyC.P., WeeseJ.L., HymanN.H.; Postoperative Ileus Study Group. Phase III trial of alvimopan, a novel, peripherally acting, mu opioid antagonist, for postoperative ileus after major abdominal surgery.Dis Colon Rectum2005; 48: 1114–25.
16.
ViscusiE.R., GoldsteinS., WitkowskiT.Alvimopan, a peripherally acting mu-opioid receptor antagonist, compared with placebo in postoperative ileus after major abdominal surgery: results of a randomized, double-blind, controlled study.Surg Endosc2006; 20: 64–70.
17.
WolffB.G., MichelassiF., GerkinT.M.Alvimopan Postoperative Ileus Study Group. Alvimopan, a novel, peripherally acting mu opioid antagonist: results of a multicenter, randomized, double blind, placebo-controlled, phase III trial of major abdominal surgery and postoperative ileus.Ann Surg2004; 240: 728–34.
18.
AbsherR.K., GerkinT.M., BanaresL.W.Alvimopan use in laparoscopic and open bowel resections: clinical results in a large community hospital system.Ann Pharmacother2010; 44: 1701–8.
19.
WangS., ShahN., PhilipJ.Role of alvimopan (Entereg) in gastrointestinal recovery and hospital length of stay after bowel resection.P&T2012; 37: 518–25.
20.
PostonS., BroderM.S., GibbonsM.M.Impact of alvimopan (Entereg) on hospital costs after bowel resection.P&T2011; 36: 209–20.
21.
SteinbrookR.A.Epidural anesthesia and gastrointestinal motility.Anesth Analg1998; 86: 837–44.
